Management of Respiratory Symptoms in Those with Serious Illness.

Respiratory symptoms are common in patients living with serious illness, both in cancer and nonmalignant conditions. Common symptoms include dyspnea (breathlessness), cough, malignant pleural effusions, airway secretions, and hemoptysis. Basic management of respiratory symptoms is within the scope of primary palliative care. There are pharmacologic and nonpharmacologic approaches to treating respiratory symptoms. This article provides clinicians with treatment approaches to these burdensome symptoms.

• Publication year

  2020

• Venue

  The Medical clinics of North America

• Publication date

  2020-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mcna.2019.12.004PMID 32312409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Паллиативная помощь больным с респираторной патологией и критическими состояниями: официальный документ Американского торакального общества Palliative care for patients with respiratory diseases and critical illnesses

  2020cited by this paper
• Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations

  2019cited by this paper
• The Pathway to Definitive Palliation of Malignant Pleural Effusions

  2019cited by this paper
• Management of Chronic Dyspnea #376

  2019cited by this paper
• Summary for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions

  2019cited by this paper
• Prevalence of dyspnea after stroke: a telephone-based survey.

  2019cited by this paper
• Fan Therapy for the Treatment of Dyspnea in Adults: a Systematic Review.

  2019cited by this paper
• Hemoptysis? Try Inhaled Tranexamic Acid.

  2018cited by this paper
• Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trial

  2018cited by this paper
• Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline

  2018cited by this paper
• Pleural Disease.

  2018cited by this paper
• Advancing a Common Understanding and Approach to Dyspnea Management. Consensus Proposal for the Chronic Breathlessness Syndrome.

  2017cited by this paper
• Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report

  2017cited by this paper
• Pharmacology of cough in palliative care

  2017cited by this paper
• Non-opioid medications for the relief of chronic breathlessness: current evidence

  2017cited by this paper
• Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer: CHEST Guideline and Expert Panel Report

  2017cited by this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

  2017cited by this paper
• US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample

  2017cited by this paper
• Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study

  2017cited by this paper
• Looking both ways before crossing the street: Assessing the benefits and risk of opioids in treating patients at risk of sleep -disordered breathing for pain and dyspnea.

  2017cited by this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

  2017cited by this paper
• Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions

  2017cited by this paper
• Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

  2017cited by this paper
• Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness

  2017cited by this paper
• CorrespondenceInhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment

  2016cited by this paper
• The Role of Noninvasive Ventilation in Patients with “Do Not Intubate” Order in the Emergency Setting

  2016cited by this paper
• Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.

  2016cited by this paper
• Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

  2016cited by this paper
• Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study

  2016cited by this paper
• CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

  2016cited by this paper
• How Long Does (S)He Have? Retrospective Analysis of Outcomes After Palliative Extubation in Elderly, Chronically Critically Ill Patients

  2016cited by this paper
• Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial.

  2016cited by this paper
• Benefits of interventions for respiratory secretion management in adult palliative care patients—a systematic review

  2016cited by this paper
• A Critical Review of the Quality of Cough Clinical Practice Guidelines.

  2016cited by this paper
• Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.

  2016cited by this paper
• Tunneled Pleural Catheter for the Treatment of Malignant Pleural Effusion: A Systematic Review and Meta-analysis

  2016cited by this paper
• Inhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment.

  2016cited by this paper
• Dyspnea as an independent predictor of mortality

  2016cited by this paper
• Pulmonary rehabilitation for chronic obstructive pulmonary disease.

  2015cited by this paper
• Interventions for cough in cancer.

  2015cited by this paper
• Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years—A Systematic Review

  2015cited by this paper
• Clinical features and survival of lung cancer patients with pleural effusions

  2015cited by this paper
• Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

  2014cited by this paper
• Palliative care in the ICU: relief of pain, dyspnea, and thirst—A report from the IPAL-ICU Advisory Board

  2014cited by this paper
• Palliative Use of Noninvasive Ventilation: Navigating Murky Waters

  2014cited by this paper
• Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review.

  2014cited by this paper
• Prevalence, impact, and treatment of death rattle: a systematic review.

  2014cited by this paper
• Opioids for refractory dyspnea

  2013cited by this paper
• An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis.

  2013cited by this paper
• Management of chronic cough in patients receiving palliative care: Review of evidence and recommendations by a task group of the Association for Palliative Medicine of Great Britain and Ireland

  2012cited by this paper
• Pathophysiologies of Dyspnea Explained: Why Might Opioids Relieve Dyspnea and Not Hasten Death?

  2012cited by this paper
• Interventions for alleviating cancer-related dyspnea: A systematic review and meta-analysis

  2012cited by this paper
• Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• American Thoracic Society Documents An Official American Thoracic Society Statement : Update on the Mechanisms , Assessment , and Management of Dyspnea

  2012cited by this paper
• Dyspnea Review for the Palliative Care Professional: Treatment Goals and Therapeutic Options

  2012cited by this paper
• An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

  2012cited by this paper
• Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• The use of opioids for dyspnea in advanced disease

  2011cited by this paper
• Articles of interest in other scholarly journals

  2011cited by this paper
• Early Prediction of In-Hospital Mortality of Patients with Hemoptysis: An Approach to Defining Severe Hemoptysis

  2011cited by this paper
• The experience of cough in patients diagnosed with lung cancer

  2011cited by this paper
• Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

  2011cited by this paper
• Dyspnea Review for the Palliative Care Professional: Assessment, Burdens, and Etiologies

  2011cited by this paper
• Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.

  2010cited by this paper
• Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

  2010cited by this paper
• American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease.

  2010cited by this paper
• A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis

  2010cited by this paper
• Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010

  2010cited by this paper
• Interventions for cough in cancer.

  2010cited by this paper
• Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.

  2009cited by this paper
• Opioid metabolism.

  2009cited by this paper
• The multiple dimensions of dyspnea: review and hypotheses.

  2009cited by this paper
• Interventions for noisy breathing in patients near to death.

  2008cited by this paper
• Total dyspnoea

  2008cited by this paper
• Interventions for alleviating cancer-related dyspnea: a systematic review.

  2008cited by this paper
• Is There a Higher Risk of Respiratory Depression in Opioid-Naïve Palliative Care Patients during Symptomatic Therapy of Dyspnea with Strong Opioids?

  2008cited by this paper
• Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

  2008cited by this paper
• Death Rattle and Oral Secretions—Second Edition #109

  2008cited by this paper
• Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis

  2008cited by this paper
• An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.

  2008cited by this paper
• Pulmonary complications of novel antineoplastic agents for solid tumors.

  2008cited by this paper
• Symptom distress and quality of life in patients with advanced congestive heart failure.

  2008cited by this paper
• How to withdraw mechanical ventilation: a systematic review of the literature.

  2007cited by this paper
• Effect of hydromorphone on ventilation in palliative care patients with dyspnea

  2007cited by this paper
• The Role of Inhaled Opioids and Furosemide for the Treatment of Dyspnea

  2007cited by this paper
• Complications of cough: ACCP evidence-based clinical practice guidelines.

  2006cited by this paper
• Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy

  2006cited by this paper
• Prognostic significance of dyspnea in patients referred for cardiac stress testing.

  2005cited by this paper
• Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.

  2005cited by this paper
• Aerosolized vasopressin is a safe and effective treatment for mild to moderate recurrent hemoptysis in palliative care patients.

  2005cited by this paper
• Ventilator withdrawal protocol.

  2003cited by this paper
• Ventilator Withdrawal Protocol (Part I) #33

  2003cited by this paper
• Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

  2003cited by this paper
• Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus.

  2003cited by this paper
• A systematic review of the use of opioids in the management of dyspnoea

  2002cited by this paper
• Clinical management of dyspnoea.

  2002cited by this paper
• Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

  2002cited by this paper
• Dyspnoea in patients with advanced cancer: incidence, causes and treatments.

  1998cited by this paper
• A national survey of end-of-life care for critically ill patients.

  1998cited by this paper
• Prediction of survival of patients terminally III with cancer. Results of an Italian prospective multicentric study

  1995cited by this paper

• Toward accurate estimation of respiratory rate from the photoplethysmogram: effect of different window period of PPG signals

  2025cites this paper
• A Qualitative Scoping Review of Massage and Massage Therapy on the Mental Health and Well-being of Individuals Living with a Serious and Potentially Life-limiting Physical Illness

  2025cites this paper
• Palliative Care and End-of-Life Decisions in Interstitial Lung Disease

  2023cites this paper
• Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

  2023cites this paper
• Assessing Respiratory Complications by Carbon Dioxide Sensing Platforms: Advancements in Infrared Radiation Technology and IoT Integration

  2022cites this paper
• Photoplethysmography-Based Respiratory Rate Estimation Algorithm for Health Monitoring Applications

  2022cites this paper
• 2022 Brazilian Thoracic Association recommendations for long-term home oxygen therapy

  2022cites this paper
• Editorial: Palliative care considerations and ethical issues in the care of Covid-19 patients.

  2021cites this paper
• Nursing interventions in intensive care unit patients with breathing difficulties: A scoping review of the evidence

  2020cites this paper